Further, SFN inhibits cell proliferation and mammosphere formation of CSCs in TNBC by decreasing the expression of cancer-specific CR1 and CRIPTO-3/TDGF1P3 genes [3]. The gene discussed is CRIPTO3; the disease is cancer.